Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

PHASE3CompletedINTERVENTIONAL

Enrollment

167

Participants

Timeline

Start Date

October 21, 2004

Primary Completion Date

April 1, 2005

Study Completion Date

April 4, 2005

Conditions

Migraine

Interventions

DRUG

MK0462, rizatriptan benzoate / Duration of Treatment: 1day

DRUG

Comparator: placebo / Duration of Treatment: 1 day

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00095004 - Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) | Biotech Hunter | Biotech Hunter